Chronic Hepatitis B Atypical
1 clinical trials · Condition
◉ Watch Chronic Hepatitis B Atypical
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability, Pharmacokinetics and Antiviral Activity of IONIS-HBVRx in Treatment-Naïve Patients With Chronic HBV Infection (NCT02981602) | GlaxoSmithKline | 2017-02-24 |
Track Chronic Hepatitis B Atypical automatically
Every clearance here is in the API, with alerts when new ones post.